Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database

IntroductionAnxiety diagnoses have surged recently during and after the COVID-19 pandemic. Lorazepam is widely recognized for its efficacy in treatment of anxiety, as well as insomnia, etc. However, the long-term safety profile of lorazepam in extensive patient populations has not been thoroughly es...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengkang Su, Zhengwei Huang, Xiaoyu Chen, Xi Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Pharmacology
Subjects:
anxiety
lorazepam
FAERS
adverse events
data mining
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1465245/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1465245/full

Similar Items